(VIANEWS) – Shares of ImmunoGen (IMGN) rose 7.49% to $6.03 at 10:49 EST on Monday, following the last session’s downward trend. NASDAQ Composite is jumping 0.25% to $14,709.90, following the last session’s downward trend. This seems, up to now, a somewhat up trend exchanging session today.
ImmunoGen’s last close was $5.65, 48.07% under its 52-week high of $10.88.
Today’s last reported volume for ImmunoGen is 368719 which is 80.24% below its average volume of 1866350.
ImmunoGen’s sales growth is 29.7% for the current quarter and 24.6% for the next. The company’s growth estimates for the present quarter and the next is a negative 28.6% and a negative 53.8%, respectively.
Year-on-year quarterly revenue growth grew by 18.2%, now sitting on 134.72M for the twelve trailing months.
ImmunoGen’s last week, last month’s, and last quarter’s current volatility was a positive 0.32%, a negative 0.77%, and a positive 2.35%, respectively.
ImmunoGen’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 0.95% (last week), 1.74% (last month), and 2.35% (last quarter), respectively.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,
ImmunoGen’s stock is considered to be oversold (<=20).
ImmunoGen’s Stock Yearly Top and Bottom Value
ImmunoGen’s stock is valued at $6.03 at 10:49 EST, way under its 52-week high of $10.88 and way higher than its 52-week low of $3.38.
ImmunoGen’s Moving Average
ImmunoGen’s value is below its 50-day moving average of $6.19 and way below its 200-day moving average of $7.34.
More news about ImmunoGen (IMGN).